Linda Neuman
Overview
Explore the profile of Linda Neuman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russo R, Gasperini S, Bubb G, Neuman L, Sloan L, Diaz G, et al.
EClinicalMedicine
. 2024 Jan;
68:102405.
PMID: 38292042
Background: Arginase 1 Deficiency (ARG1-D) is a rare debilitating, progressive, inherited, metabolic disease characterized by marked increases in plasma arginine (pArg) and its metabolites, with increased morbidity, substantial reductions in...
2.
Faraj A, Van Wijk R, Neuman L, Desai S, Blouse G, Knudsen T, et al.
CPT Pharmacometrics Syst Pharmacol
. 2023 Apr;
12(7):977-987.
PMID: 37042339
Marzeptacog alfa (activated) (MarzAA) is an activated recombinant human rFVII variant intended for subcutaneous (s.c.) administration to treat or prevent bleeding in individuals with hemophilia A (HA) or B (HB)...
3.
Faraj A, Knudsen T, Desai S, Neuman L, Blouse G, Simonsson U
CPT Pharmacometrics Syst Pharmacol
. 2022 Oct;
11(12):1628-1637.
PMID: 36191169
Marzeptacog alfa (activated) (MarzAA) is an activated recombinant human FVII (rFVIIa) variant developed as subcutaneous (s.c.) administration for the treatment or prevention of bleeding episodes in patients with hemophilia A...